Correspondence 0001140361-25-000312 from Cartesian Therapeutics, Inc. (RNAC) (CIK 0001453687) (RNAC)

Cartesian Therapeutics, Inc. (RNAC) (CIK 0001453687)
Date: Jan. 6, 2025 · CIK: 0001453687 · Accession: 0001140361-25-000312

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-283806

Date

January 6, 2025

Author

Not clearly detected

Form

CORRESP

Company

Cartesian Therapeutics, Inc. (RNAC) (CIK 0001453687)

Letter

Re:

January 6, 2025

Via EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

Attn: Doris Gama

Cartesian Therapeutics, Inc.

Registration Statement on Form S-3 (the “Registration Statement”)

File No. 333-283806

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Cartesian Therapeutics, Inc. (the “Company”) hereby respectfully requests that the effective date of the above-referenced Registration Statement be accelerated to 4:00 p.m., Eastern Time, on January 8, 2025, or as soon as practicable thereafter.

Please contact Sarah C. Griffiths of Covington & Burling LLP at (617) 603-8815 or sgriffiths@cov.com with any questions you may have regarding this request. In addition, please notify Ms. Griffiths by telephone when this request for acceleration has been granted.

Very truly yours,
CARTESIAN THERAPEUTICS, INC.

Show Raw Text

CORRESP
1
filename1.htm

      January 6, 2025

      Via EDGAR

      U.S. Securities and Exchange Commission

      Division of Corporation Finance

      100 F Street, N.E.

      Washington, DC 20549

      Attn: Doris Gama

              Re:

              Cartesian Therapeutics, Inc.

              Registration Statement on Form S-3 (the “Registration Statement”)

              File No. 333-283806

      Ladies and Gentlemen:

      Pursuant to Rule 461 under the Securities Act of 1933, as amended, Cartesian Therapeutics, Inc. (the “Company”) hereby respectfully requests that the effective date of the above-referenced Registration Statement be
        accelerated to 4:00 p.m., Eastern Time, on January 8, 2025, or as soon as practicable thereafter.

      Please contact Sarah C. Griffiths of Covington & Burling LLP at (617) 603-8815 or sgriffiths@cov.com with any questions you may have regarding this request. In addition, please notify Ms. Griffiths by telephone
        when this request for acceleration has been granted.

              Very truly yours,

              CARTESIAN THERAPEUTICS, INC.

              By:

              /s/ Carsten Brunn

              Name:

              Carsten Brunn

              Title:

              President and Chief Executive Officer

              cc:

              Brian K. Rosenzweig, Covington & Burling LLP

              Sarah C. Griffiths, Covington & Burling LLP

SecProbe.io